Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Contraception and Contraceptive Drugs

Free Subscription Articles published in Gynecol Endocrinol Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

October 2018
1. WANDRESEN G, Sgarbi F, Nisihara R
   Management of contraceptives and menstrual complaints in patients with Down syndrome.
   Gynecol Endocrinol. 2018 Oct 16:1-6. doi: 10.1080/09513590.2018.1501017.
   PubMed     Text format     Abstract available
   
   
   
2. XU Z, Meng L, Pan C, Chen X, et al
   Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
   Gynecol Endocrinol. 2018 Oct 10:1-4. doi: 10.1080/09513590.2018.1500535.
   PubMed     Text format     Abstract available
   
   
   May 2018
3. STUMPF MAM, Kluthcovsky ACGC, Okamoto JM, Schrut GCA, et al
   Acute pancreatitis secondary to oral contraceptive-induced hypertriglyceridemia: a case report.
   Gynecol Endocrinol. 2018 May 21:1-3. doi: 10.1080/09513590.2018.1473365.
   PubMed     Text format     Abstract available
   
   
   
4. RODRIGUEZ-PURATA J, Devesa M, Parriego M, Pardos C, et al
   Linking back-to-back stimulation cycles with oral contraceptives or progestins in women undergoing embryo accumulation for preimplantation genetic testing, a retrospective study.
   Gynecol Endocrinol. 2018 May 17:1-6. doi: 10.1080/09513590.2018.1473363.
   PubMed     Text format     Abstract available
   
   
   
5. FULGHESU AM, Melis F, Murru G, Canu E, et al
   Very low dose of flutamide in the treatment of hyperandrogenism.
   Gynecol Endocrinol. 2018;34:394-398.
   PubMed     Text format     Abstract available
   
   
   April 2018
6. ALTINOK ML, Ravn P, Andersen M, Glintborg D, et al
   Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
   Gynecol Endocrinol. 2018 Apr 16:1-5. doi: 10.1080/09513590.2018.1460343.
   PubMed     Text format     Abstract available
   
   
   January 2018
7. BRICHANT G, Nervo P, Albert A, Munaut C, et al
   Heterogeneity of estrogen receptor alpha and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments.
   Gynecol Endocrinol. 2018 Jan 31:1-5. doi: 10.1080/09513590.2018.1433160.
   PubMed     Text format     Abstract available
   
   
   
8. HERSHKO KLEMENT A, Frederic M, Bentov Y, Chang P, et al
   Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
   Gynecol Endocrinol. 2018 Jan 18:1-3. doi: 10.1080/09513590.2018.1427714.
   PubMed     Text format     Abstract available
   
   
   
9. MORGANTE G, Massaro MG, Di Sabatino A, Cappelli V, et al
   Therapeutic approach for metabolic disorders and infertility in women with PCOS.
   Gynecol Endocrinol. 2018;34:4-9.
   PubMed     Text format     Abstract available
   
   
   December 2017
10. ESTADELLA J, Espanol P, Ascencio F, Perello J, et al
    Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids.
    Gynecol Endocrinol. 2017 Dec 20:1-4. doi: 10.1080/09513590.2017.1417376.
    PubMed     Text format     Abstract available
    
    
    
11. NERI M, Piras B, Paoletti AM, Vallerino V, et al
    Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women.
    Gynecol Endocrinol. 2017 Dec 19:1-4. doi: 10.1080/09513590.2017.1416465.
    PubMed     Text format     Abstract available
    
    
    November 2017
12. MABROUK M, Paradisi R, Arena A, Del Forno S, et al
    Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Gynecol Endocrinol. 2017 Nov 21:1-5. doi: 10.1080/09513590.2017.1405932.
    PubMed     Text format     Abstract available
    
    
    October 2017
13. JIN P, Xie Y
    Treatment strategies for women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Oct 31:1-6. doi: 10.1080/09513590.2017.1395841.
    PubMed     Text format     Abstract available
    
    
    September 2017
14. SZUBERT M, Zietara M, Suzin J
    Conservative treatment of deep infiltrating endometriosis: review of existing options.
    Gynecol Endocrinol. 2017 Sep 27:1-5. doi: 10.1080/09513590.2017.1381837.
    PubMed     Text format     Abstract available
    
    
    
15. BALDANI DP, Skrgatic L, Ougouag R, Kasum M, et al
    The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Gynecol Endocrinol. 2017 Sep 23:1-5. doi: 10.1080/09513590.2017.1381681.
    PubMed     Text format     Abstract available
    
    
    
16. MODAFFARI P, D'alonzo M, Garbagnati M, Pecchio S, et al
    Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
    Gynecol Endocrinol. 2017 Sep 21:1-3. doi: 10.1080/09513590.2017.1380186.
    PubMed     Text format     Abstract available
    
    
    June 2017
17. KIM SW, Kim H, Ku SY, Suh CS, et al
    A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
    Gynecol Endocrinol. 2017 Jun 26:1-5. doi: 10.1080/09513590.2017.1342239.
    PubMed     Text format     Abstract available
    
    
    
18. SABBIONI L, Petraglia F, Luisi S
    Non-contraceptive benefits of intrauterine levonorgestrel administration: why not?
    Gynecol Endocrinol. 2017 Jun 6:1-8. doi: 10.1080/09513590.2017.1334198.
    PubMed     Text format     Abstract available
    
    
    May 2017
19. NERI M, Malune ME, Corda V, Piras B, et al
    Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC).
    Gynecol Endocrinol. 2017 May 9:1-5. doi: 10.1080/09513590.2017.1322574.
    PubMed     Text format     Abstract available
    
    
    April 2017
20. BAS-LANDO M, Rabinowitz R, Farkash R, Algur N, et al
    Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320376.
    PubMed     Text format     Abstract available
    
    
    
21. KEBAPCILAR AG, Ilhan TT, Dursunoglu D, Kebapcilar L, et al
    Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats.
    Gynecol Endocrinol. 2017 Apr 28:1-5. doi: 10.1080/09513590.2017.1320384.
    PubMed     Text format     Abstract available
    
    
    
22. MOROTTI E, Casadio P, Guasina F, Battaglia B, et al
    Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
    Gynecol Endocrinol. 2017 Apr 17:1-5. doi: 10.1080/09513590.2017.1306850.
    PubMed     Text format     Abstract available
    
    
    
23. GRANDI G, Mueller MD, Bersinger NA, Facchinetti F, et al
    The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1314458.
    PubMed     Text format     Abstract available
    
    
    March 2017
24. SANT'ANNA GD, Brum IS, Branchini G, Pizzolato LS, et al
    Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
    Gynecol Endocrinol. 2017 Mar 16:1-5. doi: 10.1080/09513590.2017.1301924.
    PubMed     Text format     Abstract available
    
    
    
25. TANMAHASAMUT P, Saejong R, Rattanachaiyanont M, Angsuwathana S, et al
    Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial.
    Gynecol Endocrinol. 2017 Mar 7:1-6. doi: 10.1080/09513590.2017.1296124.
    PubMed     Text format     Abstract available
    
    
    January 2017
26. WILDEMEERSCH D, Goldstuck ND, Jackers G
    Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Gynecol Endocrinol. 2017 Jan 13:1-4. doi: 10.1080/09513590.2016.1276164.
    PubMed     Text format     Abstract available
    
    
    
27. MULLER V, Kogan I, Yarmolinskaya M, Niauri D, et al
    Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
    Gynecol Endocrinol. 2017;33.
    PubMed     Text format     Abstract available
    
    
    December 2016
28. GUIDA M, Di Carlo C, Troisi J, Gallo A, et al
    The sexuological impact of hormonal contraceptives based on their route of administration.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
29. BASTIANELLI C, Farris M, Bruno Vecchio RC, Rosato E, et al
    An observational study of adherence to combined oral contraceptive regimens.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
30. SHARIFZADEH F, Aminimoghaddam S, Kashanian M, Fazaeli M, et al
    A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
31. SEIKKULA J, Anttila L, Polo-Kantola P, Bloigu R, et al
    Effect of mid-luteal phase GnRH agonist on frozen-thawed embryo transfers during natural menstrual cycles: a randomised clinical pilot study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    January 2016
32. FENG W, Jia YY, Zhang DY, Shi HR, et al
    Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
    Gynecol Endocrinol. 2016;32:147-50.
    PubMed     Text format     Abstract available
    
    
    
33. DAKHLY DM, Bayoumi YA, Gad Allah SH
    Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial.
    Gynecol Endocrinol. 2016;32:116-9.
    PubMed     Text format     Abstract available
    
    
    
34. PAOLETTI AM, Lello S, Di Carlo C, Orru M, et al
    Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation.
    Gynecol Endocrinol. 2016;32:61-4.
    PubMed     Text format     Abstract available
    
    
    
35. LAGANA AS, Giacobbe V, Triolo O, Granese R, et al
    Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
    Gynecol Endocrinol. 2016;32:408-11.
    PubMed     Text format     Abstract available
    
    
    December 2015
36. SAITO F, Tashiro H, Yamaguchi M, Honda R, et al
    Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available
    
    
    July 2015
37. POLYZOS NP, Corona R, Van De Vijver A, Blockeel C, et al
    Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: